Double-blind randomized multicenter study comparing Maalox TC tablets and ranitidine in healing of duodenal ulcers

Dig Dis Sci. 1991 Jul;36(7):911-6. doi: 10.1007/BF01297140.

Abstract

The efficacy of ranitidine 150 mg twice daily and Maalox TC three tablets four times daily were compared in patients with endoscopically confirmed duodenal ulcer. Seventy-nine patients were randomly allocated to double-blind, double-dummy treatment, stratified for smokers. Endoscopy was repeated after four weeks. Those unhealed continued treatment for a further two weeks before final endoscopy. Per protocol analysis in 53 patients showed ulcer healing rates at week 4 and at weeks 4 and 6 combined of 78 and 89% on Maalox TC, and of 81 and 91% on ranitidine, respectively. The same analysis gave overall healing rates of 81% in smokers and 100% in nonsmokers, irrespective of treatment. Both treatments provided early ulcer pain relief. Diarrhea was a commoner side effect in patients on Maalox TC. The study showed Maalox TC and ranitidine were equally effective in healing duodenal ulceration.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aluminum Hydroxide / adverse effects
  • Aluminum Hydroxide / therapeutic use*
  • Antacids / adverse effects
  • Antacids / therapeutic use*
  • Double-Blind Method
  • Drug Combinations
  • Duodenal Ulcer / drug therapy*
  • Female
  • Humans
  • Magnesium Hydroxide / adverse effects
  • Magnesium Hydroxide / therapeutic use*
  • Male
  • Middle Aged
  • Pain Measurement
  • Ranitidine / adverse effects
  • Ranitidine / therapeutic use*
  • Smoking / adverse effects

Substances

  • Antacids
  • Drug Combinations
  • aluminum hydroxide, magnesium hydroxide, drug combination
  • Aluminum Hydroxide
  • Ranitidine
  • Magnesium Hydroxide